Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

New small molecule drugs could help treat hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Baricitinib may effectively treat nail changes in alopecia areata.

Teledermatology is highly effective for diagnosing and managing hair loss.

Refugee patients face long wait times for dermatology care, worsening health disparities.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Transplanting one's own hair follicle cells can improve hair loss in men and women, and is particularly effective in women.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

New understanding and treatments for hair loss are improving, but more research is needed.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.